AEHR Stock Rockets As Earnings Beat Fuels Big Growth Bets

Aehr Test Systems stocks have been trading up by 13.07 percent amid upbeat investor sentiment on strengthening semiconductor test demand.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading AEHR

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

Fiscal Q4 results showed EPS of $0.11 versus expectations near breakeven, with revenue up 33% year over year and a clear swing back to profitability.
Record quarterly bookings of $60.7M pushed Aehr’s effective backlog to about $100.6M, signaling powerful demand across AI, silicon photonics, and power semiconductor markets.
Management guided fiscal 2027 revenue to $130–$150M, implying 160%–200% growth and 18%–22% non-GAAP net margins, far above prior Street estimates near $85M.
New silicon carbide burn‑in orders above $8M tied to China EV programs and a top‑two global automaker highlight AEHR’s growing foothold in next‑gen EV platforms.
Bullish analyst moves, including price targets lifted into the $110–$125 range, helped AEHR rip roughly 27%–31% on heavy volume as traders repriced the story.

Live Update At 15:03:33 EDT: On Monday, August 03, 2026 Aehr Test Systems stock [NASDAQ: AEHR] is trending up by 13.07%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

AEHR has shifted from story stock to numbers-backed momentum. The company’s latest quarter delivered revenue of about $18.8M, up 33% year over year, and EPS of $0.11 after a loss a year ago. For traders, that swing to profit is key. It shows the business can scale, not just talk about big markets.

On the balance sheet, Aehr Test Systems looks cash‑rich and low‑debt. Cash sits around $116.5M, with total liabilities of roughly $27.2M and a current ratio above 10. That kind of buffer gives AEHR room to ride out industry swings and still fund growth. Margins are rebuilding off a weak stretch, with gross margin in the mid‑30% range and targeted non‑GAAP net margins of 18%–22% by fiscal 2027.

More Breaking News

The chart backs up the story. After consolidating in the $70s and $80s, AEHR closed near $90.44 on 2026/08/03, up sharply from late July levels around the mid‑60s. Intraday action shows steady bids and higher lows all day, not just a one‑candle spike. For active trading, this is classic post‑earnings trend behavior with buyers in control and shorts on their heels.

Why Traders Are Watching AEHR Right Now

Momentum in AEHR is not coming from hype alone; the company just printed the kind of quarter growth traders love. Aehr Test Systems swung to a fiscal Q4 profit with EPS of $0.11, beating expectations that ranged from flat to a loss. Revenue grew 33% year over year, and that upside helped trigger a 27%–31% surge in AEHR shares as traders rushed to reprice the name.

The standout metric was bookings. AEHR landed a record $60.7M in quarterly orders and exited with an effective backlog around $100.6M. For anyone trading growth names, that backlog is the fuel for the next legs of revenue, especially when it’s tied to real end markets like AI processors, silicon photonics, and power semiconductors.

The growth story gets louder with management’s fiscal 2027 guide. AEHR is targeting $130–$150M in revenue, 160%–200% above the prior year, plus non‑GAAP net margins of 18%–22%. That is a massive reset versus prior Street expectations of roughly $85M and explains why Lake Street doubled its AEHR price target to $110 and Craig‑Hallum went even further, hiking to $125. Freedom Broker also upgraded AEHR to Buy and raised its target to $110, framing this as a long‑awaited growth inflection.

On the demand side, AEHR is stacking proof points. The company announced over $8M in new silicon carbide wafer‑level burn‑in orders, including a key follow‑on from its lead SiC customer expanding EV programs in China and a qualification order with one of the world’s top two automakers. Add in a follow‑on FOX‑XP silicon photonics system for AI optical interconnects and hyperscale data centers, and traders can see why AEHR is becoming an AI and EV infrastructure play, not just another test‑equipment ticker.

Conclusion

AEHR is now firmly on the radar of momentum and swing traders. A 26%–30% post‑earnings pop to about $91.20, followed by closes near $90, shows the market is treating the fiscal Q4 beat and FY27 guidance as a real turning point. Record bookings, a $100M‑plus effective backlog, and strong cash on hand set Aehr Test Systems up as a levered play on AI data centers, silicon photonics, and EV power devices.

That said, the bar is now high. AEHR’s price‑to‑sales is rich, and the stock already reflated fast from the mid‑$60s to near $90 in a matter of sessions. For traders, this is where discipline matters: watch how AEHR trades around prior breakout levels, track volume on pullbacks, and respect the fact that expectations for $130–$150M in fiscal 2027 revenue leave little room for big execution mistakes.

The AEHR setup lines up well with the mindset Tim Sykes drills into his community: “The market rewards preparation, not predictions. Study the runs, learn the patterns, and always be ready to cut losses fast when the story changes.” That philosophy echoes the way short-term momentum pros approach hot names. As Tim Bohen, lead trainer with StocksToTrade says, “I focus on momentum that’s visible right now. Speculation on future moves is outside my playbook.” AEHR is delivering the kind of real numbers and sector tailwinds that draw in aggressive trading, but like every hot runner, the edge goes to those who stay nimble, data‑driven, and brutally honest with their risk.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!